168 related articles for article (PubMed ID: 31919899)
1. The basic helix-loop-helix transcription factor TCF4 impacts brain architecture as well as neuronal morphology and differentiation.
Schoof M; Hellwig M; Harrison L; Holdhof D; Lauffer MC; Niesen J; Virdi S; Indenbirken D; Schüller U
Eur J Neurosci; 2020 Jun; 51(11):2219-2235. PubMed ID: 31919899
[TBL] [Abstract][Full Text] [Related]
2. Enriched environment ameliorates adult hippocampal neurogenesis deficits in Tcf4 haploinsufficient mice.
Braun K; Häberle BM; Wittmann MT; Lie DC
BMC Neurosci; 2020 Nov; 21(1):50. PubMed ID: 33228529
[TBL] [Abstract][Full Text] [Related]
3. Common Pathophysiology in Multiple Mouse Models of Pitt-Hopkins Syndrome.
Thaxton C; Kloth AD; Clark EP; Moy SS; Chitwood RA; Philpot BD
J Neurosci; 2018 Jan; 38(4):918-936. PubMed ID: 29222403
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the expression pattern of the schizophrenia-risk and intellectual disability gene TCF4 in the developing and adult brain suggests a role in development and plasticity of cortical and hippocampal neurons.
Jung M; Häberle BM; Tschaikowsky T; Wittmann MT; Balta EA; Stadler VC; Zweier C; Dörfler A; Gloeckner CJ; Lie DC
Mol Autism; 2018; 9():20. PubMed ID: 29588831
[TBL] [Abstract][Full Text] [Related]
5. Functional consequences of TCF4 missense substitutions associated with Pitt-Hopkins syndrome, mild intellectual disability, and schizophrenia.
Sirp A; Roots K; Nurm K; Tuvikene J; Sepp M; Timmusk T
J Biol Chem; 2021 Dec; 297(6):101381. PubMed ID: 34748727
[TBL] [Abstract][Full Text] [Related]
6. Impairment of different protein domains causes variable clinical presentation within Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4.
Bedeschi MF; Marangi G; Calvello MR; Ricciardi S; Leone FPC; Baccarin M; Guerneri S; Orteschi D; Murdolo M; Lattante S; Frangella S; Keena B; Harr MH; Zackai E; Zollino M
Eur J Med Genet; 2017 Nov; 60(11):565-571. PubMed ID: 28807867
[TBL] [Abstract][Full Text] [Related]
7. Molecular and Cellular Function of Transcription Factor 4 in Pitt-Hopkins Syndrome.
Chen HY; Bohlen JF; Maher BJ
Dev Neurosci; 2021; 43(3-4):159-167. PubMed ID: 34134113
[TBL] [Abstract][Full Text] [Related]
8. Disordered breathing in a Pitt-Hopkins syndrome model involves Phox2b-expressing parafacial neurons and aberrant Nav1.8 expression.
Cleary CM; James S; Maher BJ; Mulkey DK
Nat Commun; 2021 Oct; 12(1):5962. PubMed ID: 34645823
[TBL] [Abstract][Full Text] [Related]
9. Pitt-Hopkins Syndrome: intellectual disability due to loss of TCF4-regulated gene transcription.
Sweatt JD
Exp Mol Med; 2013 May; 45(5):e21. PubMed ID: 23640545
[TBL] [Abstract][Full Text] [Related]
10. TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma.
Hellwig M; Lauffer MC; Bockmayr M; Spohn M; Merk DJ; Harrison L; Ahlfeld J; Kitowski A; Neumann JE; Ohli J; Holdhof D; Niesen J; Schoof M; Kool M; Kraus C; Zweier C; Holmberg D; Schüller U
Acta Neuropathol; 2019 Apr; 137(4):657-673. PubMed ID: 30830316
[TBL] [Abstract][Full Text] [Related]
11. Rescue of behavioral and electrophysiological phenotypes in a Pitt-Hopkins syndrome mouse model by genetic restoration of
Kim H; Gao EB; Draper A; Berens NC; Vihma H; Zhang X; Higashi-Howard A; Ritola KD; Simon JM; Kennedy AJ; Philpot BD
Elife; 2022 May; 11():. PubMed ID: 35535852
[TBL] [Abstract][Full Text] [Related]
12. A typical variant in TCF4 exon 18 is not associated with Pitt-Hopkins syndrome but with a familial case of mild and nonspecific neurodevelopmental disorder.
Aldeeri AA; Abu-El-Haija A
Am J Med Genet A; 2023 Apr; 191(4):1070-1076. PubMed ID: 36574749
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome.
Forrest M; Chapman RM; Doyle AM; Tinsley CL; Waite A; Blake DJ
Hum Mutat; 2012 Dec; 33(12):1676-86. PubMed ID: 22777675
[TBL] [Abstract][Full Text] [Related]
14. Repurposing the Dihydropyridine Calcium Channel Inhibitor Nicardipine as a Na
Ekins S; Puhl AC; Davidow A
Pharm Res; 2020 Jun; 37(7):127. PubMed ID: 32529312
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Na
Martinowich K; Das D; Sripathy SR; Mai Y; Kenney RF; Maher BJ
Mol Psychiatry; 2023 Jan; 28(1):76-82. PubMed ID: 36224259
[TBL] [Abstract][Full Text] [Related]
16. Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects.
Sepp M; Pruunsild P; Timmusk T
Hum Mol Genet; 2012 Jul; 21(13):2873-88. PubMed ID: 22460224
[TBL] [Abstract][Full Text] [Related]
17. Complex translocation disrupting TCF4 and altering TCF4 isoform expression segregates as mild autosomal dominant intellectual disability.
Maduro V; Pusey BN; Cherukuri PF; Atkins P; du Souich C; Rupps R; Limbos M; Adams DR; Bhatt SS; Eydoux P; Links AE; Lehman A; Malicdan MC; Mason CE; Morimoto M; Mullikin JC; Sear A; Van Karnebeek C; Stankiewicz P; Gahl WA; Toro C; Boerkoel CF
Orphanet J Rare Dis; 2016 May; 11(1):62. PubMed ID: 27179618
[TBL] [Abstract][Full Text] [Related]
18. Langerhans cell histiocytosis in a young patient with Pitt-Hopkins syndrome.
Macchiaiolo M; Panfili FM; Gonfiantini MV; Mastrogiorgio G; Buonuomo PS; Gaspari S; Longo D; Zollino M; Bartuli A
Am J Med Genet A; 2020 Nov; 182(11):2746-2750. PubMed ID: 32945094
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor 4 and its association with psychiatric disorders.
Teixeira JR; Szeto RA; Carvalho VMA; Muotri AR; Papes F
Transl Psychiatry; 2021 Jan; 11(1):19. PubMed ID: 33414364
[TBL] [Abstract][Full Text] [Related]
20. A case of Pitt-hopkins Syndrome with de novo mutation in TCF4: Clinical features and treatment for epilepsy.
Liu Y; Guo Y; Liu P; Li F; Yang C; Song J; Hu J; Xin D; Chen Z
Int J Dev Neurosci; 2018 Jun; 67():51-54. PubMed ID: 29604340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
